Publications by authors named "Gregg Masters"

Claim this Profile
I
Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor models.
Katherine E Lewis, Mark J Selby, Gregg Masters, Jose Valle, Gennaro Dito

Oncoimmunology· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paradoxical activation of T cells via augmented ERK signaling mediated by a RAF inhibitor.
Margaret K Callahan, Gregg Masters, Christine A Pratilas, Charlotte Ariyan, Jessica Katz

Cancer Immunol Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergy between chemotherapeutic agents and CTLA-4 blockade in preclinical tumor models.
Maria Jure-Kunkel, Gregg Masters, Emel Girit, Gennaro Dito, Francis Lee

Cancer Immunol Immunother· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic effects of combined therapy using paclitaxel and [90Y-DOTA]776.1 on growth of OVCAR-3 ovarian carcinoma xenografts.
Gregg R Masters, Marc A Berger, Earl F Albone

Gynecol Oncol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, biodistribution, and radioimmunotherapy with monoclonal antibody 776.1 in a murine model of human ovarian cancer.
Marc A Berger, Gregg R Masters, Judith Singleton, Michael S Scully, Lisa G Grimm

Cancer Biother Radiopharm· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy of human xenograft NSCLC tumors in nude mice with a 90Y-labeled anti-tissue factor antibody.
Baiyang Wang, Marc Berger, Gregg Masters, Earl Albone, Qifeng Yang

Cancer Biother Radiopharm· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis